Key immune driver of pancreatic cancer points to combination treatment for slowing progression
Researchers from The University of Texas MD Anderson Cancer Center have discovered that the IL-18 inflammatory protein helps pancreatic tumors grow and evade the immune system, highlighting its potential as a therapeutic target for pancreatic cancer.
We haven't written up this one. Medical Xpress has the full story — the link below goes straight to it.